BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12085174)

  • 41. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
    Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
    Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome.
    Segal K; Shpitzer T; Hazan A; Bachar G; Marshak G; Popovtzer A
    Otolaryngol Head Neck Surg; 2006 May; 134(5):819-22. PubMed ID: 16647541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases.
    Nel CJ; van Heerden JA; Goellner JR; Gharib H; McConahey WM; Taylor WF; Grant CS
    Mayo Clin Proc; 1985 Jan; 60(1):51-8. PubMed ID: 3965822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of surgery in the treatment of thyroid anaplastic carcinoma in the elderly.
    Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Rondelli F; Bugiantella W; Barillaro I; Sanguinetti A; Avenia N
    Int J Surg; 2014; 12 Suppl 2():S170-S176. PubMed ID: 25167852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period.
    Nilsson O; Lindeberg J; Zedenius J; Ekman E; Tennvall J; Blomgren H; Grimelius L; Lundell G; Wallin G
    World J Surg; 1998 Jul; 22(7):725-30. PubMed ID: 9606289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
    Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
    Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell.
    Austin JR; el-Naggar AK; Goepfert H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):611-27. PubMed ID: 8844733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
    Vrbic S; Pejcic I; Vrbic M; Filipovic S
    J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaplastic Carcinoma Thyroid - A Review on the Management of this Aggressive Cancer.
    Hussain SA; Subbiah S; Bharathiraja MS
    Gulf J Oncolog; 2018 Sep; 1(28):37-41. PubMed ID: 30344132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution.
    Segerhammar I; Larsson C; Nilsson IL; Bäckdahl M; Höög A; Wallin G; Foukakis T; Zedenius J
    J Surg Oncol; 2012 Dec; 106(8):981-6. PubMed ID: 22674491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New therapeutic approach for mixed anaplastic carcinoma of the thyroid.
    St Cyr JA; Shearen J; Delaney JP
    Minn Med; 1985 Dec; 68(12):893, 895-6, 901. PubMed ID: 4088180
    [No Abstract]   [Full Text] [Related]  

  • 55. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model.
    Marano F; Frairia R; Rinella L; Argenziano M; Bussolati B; Grange C; Mastrocola R; Castellano I; Berta L; Cavalli R; Catalano MG
    Endocr Relat Cancer; 2017 Jun; 24(6):275-286. PubMed ID: 28487350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.
    Junor EJ; Paul J; Reed NS
    Eur J Surg Oncol; 1992 Apr; 18(2):83-8. PubMed ID: 1582515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimodality treatment in anaplastic giant cell thyroid carcinoma.
    Tallroth E; Wallin G; Lundell G; Löwhagen T; Einhorn J
    Cancer; 1987 Oct; 60(7):1428-31. PubMed ID: 2441842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New trends in the treatment of undifferentiated carcinomas of the thyroid.
    Miccoli P; Materazzi G; Antonelli A; Panicucci E; Frustaci G; Berti P
    Langenbecks Arch Surg; 2007 Jul; 392(4):397-404. PubMed ID: 17131154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaplastic carcinoma of the thyroid.
    Sweeney PJ; Haraf DJ; Recant W; Kaplan EL; Vokes EE
    Ann Oncol; 1996 Sep; 7(7):739-44. PubMed ID: 8905033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.